
doi: 10.1002/jso.23749
pmid: 25164477
AbstractPeritoneal metastasis (PM) has traditionally been approached with therapeutic nihilism. The evolution of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) over the last two decades, however, has caused a paradigm shift in treatment for PM. This modality is rapidly gaining acceptance as standard of care for PM from various cancers. This article reviews the current literature regarding the use of CRS/HIPEC for PM from the most common intra‐abdominal malignancies. J. Surg. Oncol. 2014 110:575–584. © 2014 Wiley Periodicals, Inc.
Cytoreduction Surgical Procedures, Hyperthermia, Induced, Combined Modality Therapy, Treatment Outcome, Abdominal Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Colorectal Neoplasms, Peritoneal Neoplasms
Cytoreduction Surgical Procedures, Hyperthermia, Induced, Combined Modality Therapy, Treatment Outcome, Abdominal Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Humans, Female, Colorectal Neoplasms, Peritoneal Neoplasms
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 53 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
